Pharma firm fights AZ rec legalization measure

A publicly traded pharmaceutical firm in Arizona that is developing both opiate and cannabis-based medicines is also the largest contributor to opponents of the campaign to legalize recreational marijuana in the state.

Insys Therapeutics, based in Chandler, donated $500,000 to Arizonans for Responsible Drug Policy, the Arizona Capital Times reported. The second largest donation to the anti-legalization group was $110,000 from the Arizona Chamber of Commerce and Industry.

Insys’ only currently available product is an opiate spray to treat pain for cancer patients

The company also has several drugs going through Food and Drug Administration trials, including Cannabidiol, which would be used to treat pediatric epilepsy.

Insys said in a statement it has nothing against cannabinoids as long as they are used properly. “We believe that all available medicines should meet the clinical standards set by the FDA,” the statement said, according to the Arizona Capital Times.

The head of Arizona’s legalization effort, J.P. Holyoak, said Insys is opposing recreational marijuana legalization because it would cut into the company’s profits.

“They want to be able to push their far more addictive, far more harmful and far more dangerous opioid drugs,” Holyoak said.

5 comments on “Pharma firm fights AZ rec legalization measure
  1. Kelley Mottola on

    Of Course, it is all about the money and who has the most wins. Absolutely ridiculous, has nothing to do with helping people. They all just want their piece and forget anyone that already has knowledge of growing and experimenting with marijuana. As we are seeing each state is reinventing the wheel, instead of looking at states that do have some form of legalization and comparing what is working and what isn’t. Why? It cost more money to implement all these different rules and regulations in each state then it does to allow people to grow and ingest their own. Not to mention, the legality issues from one state to another.

    Reply
  2. Pam on

    If Insys has a product that is good then they don’t need to worry about competition from the hippy chick down the street making tinctures.
    This is a move by a company that does not have self worth nor confidence in their ability to formulate a viable product.

    Reply
  3. Colin on

    This is absolutely disgusting, and epitomizes the nasty pharmaceutical companies profiteering agendas. It’s nice that the companies Fentanol spray is for “cancer patients”, but can a doctor prescribe it for other ailments? The answer is YES. And that’s where our nation wide epidemic of opiod addiction comes in. Is anyone dying of cannabis overdose? NO! But fentanol, oxycontin, vicodin and codein? Daily, and in staggering numbers. Arizona, don’t let these biggot’s influence your right to choose a less harmful medical and recreational intoxicant than alcohol and opiates! Cannabis is SAFER!

    Reply
  4. John Dickinson on

    Perhaps we should follow from where they are importing their opium. The US uses over 90% of the world’s opium supply while over 80% of the world’s population has none, “zero or very little” World Heath Org quote. The health problems we have stems from the addictive drugs that we all have at home and use. Anyone using opioids or alcohol, these addicts, should get a medical card, and not be allowed to own guns.

    Reply
  5. Bruce on

    A battle of who has the most money and the lowest moral values. And the loser is….. Patients, Consumers, taxpayers, pretty much everyone but those owners that have bought the Az game and rigged the laws. A big F U to the MPP and anyone that backs them.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *